![A new whole genome and health assessment service in Australia combines Genome.One's genome sequencing with pharmacogenomic testing using the RightMed® test of OneOme. [© cutimage/Fotolia] A new whole genome and health assessment service in Australia combines Genome.One's genome sequencing with pharmacogenomic testing using the RightMed® test of OneOme. [© cutimage/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1157.jpeg)
Whole-genome sequencing has become an important tool for diagnosing genetic diseases in critically ill newborns and young children. But what about adolescents who receive a genetic diagnosis years later? Could some of those conditions have been identified at birth?
New research from Rady Children’s Institute for Genomic Medicine suggests that rapid and ultra-rapid whole-genome sequencing can provide diagnostic answers during adolescence. The findings also raise questions about whether broader newborn screening could shorten the time to diagnosis for some patients.
The study, presented by Jennifer Schleit, PhD, at the Association for Molecular Pathology (AMP) 2026 Annual Meeting, examined 177 adolescents aged 13 to 19 who underwent clinical genomic testing between 2021 and 2025. Researchers retrospectively reviewed results from 117 patients (66.1%) who received rapid whole-genome sequencing and 60 (33.9%) who underwent ultra-rapid sequencing. Positive findings were reported in 64 patients (36.2%), while 39 (22%) received uncertain results and 74 (41.8%) had negative findings. Cardiac and neurological conditions were the most common reasons for testing, with positive findings reported in 37.7% and 35.4% of these patients, respectively.
An understudied age group
Most research on rapid whole-genome sequencing has focused on newborns and critically ill young children, where identifying an underlying genetic disorder quickly can guide urgent treatment decisions. Although genomic sequencing is also used in older children, relatively few studies have examined adolescents as a distinct population.
One previous study, NYCKidSeq, evaluated genomic sequencing in children and young adults with suspected genetic disorders. Among 238 adolescents and young adults older than 12, researchers reported a molecular diagnostic yield of 14.7%.
The Rady study’s 36.2% positive finding rate was considerably higher, although differences in patient selection, testing approaches, and definitions of positive findings make direct comparisons difficult.
Implications for newborn screening
Beyond evaluating diagnostic findings in adolescents, Schleit and colleagues investigated whether some of those conditions could have been identified through BeginNGS, a whole-genome sequencing-based newborn screening program developed at Rady. BeginNGS evaluates 507 early-onset genetic disorders and reports variants classified as pathogenic or likely pathogenic, meaning they are known or strongly suspected to cause disease.
When researchers compared the adolescents’ results with the program’s current reporting criteria, they found that eight of the 64 positive findings (13%) would have qualified for reporting through BeginNGS.
The findings are relevant to ongoing efforts to expand newborn screening beyond the conditions included in conventional screening panels. Unlike diagnostic genomic testing, which is generally performed when a genetic disorder is suspected, newborn genomic screening aims to identify certain conditions before symptoms emerge. However, detecting a genetic condition earlier does not necessarily mean that treatment or outcomes would improve. That depends on the disorder, the availability of effective interventions, and whether action before symptoms develop would offer a clinical benefit. The study also involved adolescents already selected for clinical testing, meaning its diagnostic yield cannot be generalized to the broader newborn population.
The findings underscore the value of genomic testing beyond infancy while providing evidence that a subset of genetic diagnoses made during adolescence could have been established years earlier.


